THYMIDINE LABELING INDEX AS PROGNOSTIC FACTOR IN RESECTED NON-SMALL CELL LUNG-CANCER

被引：27

作者：

ALAMA, A ^{[1
]}

COSTANTINI, M ^{[1
]}

REPETTO, L ^{[1
]}

CONTE, PF ^{[1
]}

SERRANO, J ^{[1
]}

NICOLIN, A ^{[1
]}

BARBIERI, F ^{[1
]}

ARDIZZONI, A ^{[1
]}

BRUZZI, P ^{[1
]}

机构：

[1] OSPED SAN MARTINO GENOVA,GENOA,ITALY

来源：

EUROPEAN JOURNAL OF CANCER | 1990年 / 26卷 / 05期

关键词：

D O I：

10.1016/0277-5379(90)90093-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

To assess the prognostic value of tumor proliferative activity, 89 patients with operable non-small cell lung cancer were studied. Tumor samples were obtained during surgery and cell kinetics were analyzed by the in vitro thymidine labelling index (TLI). The overall median TLI (2.9) was used to identify two subsets of patients with high and low proliferating tumors. In univariate analysis survival was significantly longer in patients with lower TLI (P = 0.047) and with stage I-II (P = 0.003) and T1-T2 tumors (P = 0.043). In multivariate analysis, stage was the most important prognostic parameter (P = 0.004). The risk of death for patients with TLI higher than 2.9 was increased (hazard ratio = 2.01, CI = 0.96-4.27). © 1990.

引用

页码：622 / 625

页数：4

共 50 条

[1] The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer
Mori, Shunsuke
Usami, Noriyasu
Fukumoto, Koichi
Mizuno, Tetsuya
Kuroda, Hiroaki
Sakakura, Noriaki
Yokoi, Kohei
Sakao, Yukinori
PLOS ONE, 2015, 10 (09):
[2] PROGNOSTIC-SIGNIFICANCE OF THE PROLIFERATION INDEX IN SURGICALLY RESECTED NON-SMALL-CELL LUNG-CANCER
PENCE, JC
KERNS, BJM
DODGE, RK
IGLEHART, JD
ARCHIVES OF SURGERY, 1993, 128 (12) : 1382 - 1390
[3] PROGNOSTIC-SIGNIFICANCE OF KI67 LABELING IN RESECTED NON-SMALL-CELL LUNG-CANCER
SCAGLIOTTI, GV
MICELA, M
GUBETTA, L
LEONARDO, E
CAPPIA, S
BORASIO, P
POZZI, E
EUROPEAN JOURNAL OF CANCER, 1993, 29A (03) : 363 - 365
[4] Prognostic Importance of the Lymph Node Factor in Surgically Resected Non-Small Cell Lung Cancer
Tezel, Cagatay
Dogruyol, Talha
Alpay, Levent
Akyil, Mustafa
Evman, Serdar
Metin, Serda
Baysungur, Volkan
Yalcinkaya, Irfan
THORACIC AND CARDIOVASCULAR SURGEON, 2020, 68 (02): : 183 - 189
[5] Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer
Kessler, R
Gasser, B
Massard, G
Roeslin, N
Meyer, P
Wihlm, JM
Morand, G
ANNALS OF THORACIC SURGERY, 1996, 62 (05): : 1489 - 1493
[6] SURGICAL ADJUVANT IMMUNOTHERAPY IN PATIENTS WITH RESECTED NON-SMALL CELL LUNG-CANCER
WRIGHT, PW
HILL, LD
PETERSON, AV
BAGLEY, CM
IVEY, T
JOHNSON, LP
OSTENSEN, R
PINKHAM, R
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 368 - 368
[7] NON-SMALL CELL LUNG-CANCER
HASKELL, CM
HOLMES, EC
CURRENT PROBLEMS IN CANCER, 1987, 11 (01) : 1 - 53
[8] NON-SMALL CELL LUNG-CANCER
HASKELL, CM
HOLMES, EC
DM DISEASE-A-MONTH, 1988, 34 (02): : 55 - 108
[9] Prognostic value of perioperative changes in the prognostic nutritional index in patients with surgically resected non-small cell lung cancer
Hayasaka, Kazuki
Notsuda, Hirotsugu
Onodera, Ken
Watanabe, Tatsuaki
Watanabe, Yui
Suzuki, Takaya
Hirama, Takashi
Oishi, Hisashi
Niikawa, Hiromichi
Okada, Yoshinori
SURGERY TODAY, 2024, 54 (09) : 1031 - 1040
[10] Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer
Li, HX
Zhang, S
Lei, DS
Wang, XQ
Skog, S
He, Q
ONCOLOGY REPORTS, 2005, 13 (01) : 145 - 149

← 1 2 3 4 5 →